Caribou Biosciences (CRBU) Profit After Tax (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Profit After Tax came in at -$126000.0 in Q1 2026, up 99.69% year-on-year from -$63099.2 in Q1 2025, and up 99.52% on a QoQ basis from -$26.5 million in Q4 2025.
Caribou Biosciences (CRBU) Profit After Tax (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Profit After Tax data on file, last reported at -$126000.0 in Q1 2026.
- On a quarterly basis, Profit After Tax rose 99.69% year-over-year to -$126000.0 in Q1 2026; TTM through Mar 2026 was -$26.7 million, a 75.63% increase from a year earlier, with the FY2025 full-year figure at -$148.1 million, up 0.51% from the prior year.
- Profit After Tax for Q1 2026 stood at -$126000.0, up from -$26.5 million in the prior quarter.
- Over the last five years, Profit After Tax for CRBU reached as high as $71.0 million in Q4 2022 and fell as low as -$40.1 million in Q1 2025.
- Historically, Profit After Tax has averaged -$9.2 million across 5 years, with a median of -$492000.0 in 2022.
- Across the five-year window, Profit After Tax jumped 484.49% in 2022 and plunged 11286.08% in 2025, its largest moves.
- Year by year, Profit After Tax stood at $71.0 million in 2022, then slumped by 148.57% to -$34.5 million in 2023, then fell by 4.4% to -$36.0 million in 2024, then advanced by 26.37% to -$26.5 million in 2025, then surged by 99.52% to -$126000.0 in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$126000.0 in Q1 2026, -$26.5 million in Q4 2025, and $53000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -126,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,000.00 |
| Dec 31, 2025 | -26.53 Mn |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -40.08 Mn |
| Dec 31, 2024 | -36.02 Mn |
| Sep 30, 2024 | -33.58 Mn |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -352,000.00 |
| Dec 31, 2023 | -34.51 Mn |
| Sep 30, 2023 | -9.85 Mn |
| Jun 30, 2023 | -406,000.00 |
| Mar 31, 2023 | 788,000.00 |
| Dec 31, 2022 | 71.05 Mn |
| Sep 30, 2022 | -26.65 Mn |
| Jun 30, 2022 | -492,000.00 |
| Mar 31, 2022 | -19.09 Mn |
| Dec 31, 2021 | -18.48 Mn |
| Sep 30, 2021 | -20.97 Mn |
| Jun 30, 2021 | -14.31 Mn |